Phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma | Dr Sumanta Pal at Annual Meeting 2015 - 101271

Spotlight
Video

Phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma | Dr Sumanta Pal at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sumanta K. Pal, MD, of City of Hope Comprehensive Cancer Center, Duarte, CA, discusses the results of a randomised, phase 2, three-arm trial of lenvatinib, everolimus, and lenvatinib combined with everolimus in patients with metastatic renal cell carcinoma.
Shared By : EMJ
Posted on : 09/01/15
Added : 3 years ago
Category : Kidney Cancer